Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC) - Wikidata - awgldk - TriplyDB

Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC)

Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC)

http://www.wikidata.org/entity/Q28750566

about

sameAs

The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon Platform for Plasmodium vivax vaccine discovery and development The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic Variants DARC alleles and Duffy phenotypes in African Americans Duffy antigen receptor for chemokine (DARC) polymorphisms and its involvement in acquisition of inhibitory anti-duffy binding protein II (DBPII) immunity.Blood Groups in Infection and Host Susceptibility.Analysis for genotyping Duffy blood group in inhabitants of Sudan, the fourth cataract of the Nile Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses The host genetic diversity in malaria infection.What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development.Susceptibility to Plasmodium vivax malaria associated with DARC (Duffy antigen) polymorphisms is influenced by the time of exposure to malaria

P2860

Q27009149-968DDDC0-6B19-43D7-BE4D-FE0C54115B8C Q27021891-20F29365-6A3D-42C8-8DAA-7583D477F928 Q28396379-DE43E234-6D28-4E90-899E-3C1D98CCF528 Q28728559-D2B0377A-A7CC-48EA-8DB7-4E7AC7D2E057 Q35141958-7C8B1AC9-336E-47A6-9CF8-FD55D471F2EA Q35763408-A78D3379-2213-405F-BAB5-20258A77C278 Q36032160-F35E52AA-9468-44A6-97E9-6C64195C92B0 Q36213254-3E5EB3AB-DF7B-4FA6-B171-FC2E0C23964C Q36495726-A91CB1F0-70EE-4B03-A566-72AE5F8F0350 Q37638131-959B367D-8E81-459E-956C-4CB085BBCDF2 Q41994105-53441F71-4350-42BF-B8C9-6DE402DF1AAF Q57157434-AB6EDA8B-F331-4E89-BBD9-517D027F4A1C

P2860

Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC)

http://www.wikidata.org/entity/Q28750566

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Acquired antibody responses ag ...... receptor for chemokines (DARC)

@ast

Acquired antibody responses ag ...... receptor for chemokines (DARC)

@en

Acquired antibody responses ag ...... receptor for chemokines (DARC)

@nl

type

label

Acquired antibody responses ag ...... receptor for chemokines (DARC)

@ast

Acquired antibody responses ag ...... receptor for chemokines (DARC)

@en

Acquired antibody responses ag ...... receptor for chemokines (DARC)

@nl

prefLabel

Acquired antibody responses ag ...... receptor for chemokines (DARC)

@ast

Acquired antibody responses ag ...... receptor for chemokines (DARC)

@en

Acquired antibody responses ag ...... receptor for chemokines (DARC)

@nl

P1433

Q28750566-44792165-2842-4D9F-8851-30E1D28CBC3A

P1476

Q28750566-2BD9597B-9E57-4962-ADC7-BF6CD471AA46

P2093

Q28750566-180B2297-1A27-4789-9D21-EFF59BD72527

Q28750566-2A12B1EC-20B6-494A-BA76-DFB85477FB6C

Q28750566-31F5FCCE-F919-427A-82C5-B60B900D1C9E

Q28750566-4FE9A7E5-1B27-4C92-BAD3-86B80F771BE8

Q28750566-54792576-1191-4E90-B111-C3E581963C38

Q28750566-82306028-BAC1-4537-A423-1E557D897716

Q28750566-BC6E1A60-3CE7-4E68-971B-F635412E84F3

Q28750566-E1639222-FCCB-47A3-A3E1-85238F2C6D12

Q28750566-E4B8369C-AF48-4192-9E61-F8706703E971

Q28750566-ECF49BB5-33CE-40BC-8C00-4E94DFFF59FB

P2860

Q28750566-05926F17-DE34-4E18-8966-055CF3A7D902

Q28750566-073A4006-45AE-4CBE-B39A-0DCE2B16CBC3

Q28750566-08A3F11D-B288-47BA-9BF0-16D9AF3E2F30

Q28750566-10935CC6-8BCB-4F6A-B644-24074AC3E004

Q28750566-1B61EAF2-FB56-4B7A-9B6F-78F86F93ED7F

Q28750566-1BA374E4-24CE-48A6-9FDF-E630138338D5

Q28750566-1D35D61C-5EB5-4FBA-AE0B-D71D4D511379

Q28750566-215DA6EE-4242-47A6-A3C6-C327D5239314

Q28750566-2E96FC16-0FF0-4B55-B1E0-1A092BF8601D

Q28750566-2FAE3D73-3453-4992-B919-E7166FD02F05

P304

Q28750566-69F60AF9-3A7D-485F-BDE5-96D1ED0996F6

P31

Q28750566-C870B382-7DAC-4A01-A0A6-0E0474861646

P356

Q28750566-66FDEC52-901A-4C29-ACE5-37DA825A7511

P407

Q28750566-9869DBF8-6425-4D1E-9825-009BB0E5171F

P433

Q28750566-BDA6C20E-CBC2-4F34-A5FC-52127C69D195

P478

Q28750566-B92B26FE-25FE-4255-8BAC-985508857FEB

P50

Q28750566-0A91D84E-A708-4418-A356-2C11CCA7B0AF

Q28750566-845A0394-0E59-4153-803E-9DA4070A29B2

Q28750566-986CCAF3-2F10-4754-9929-A25949106A4F

P577

Q28750566-FEB8E917-4B2F-4E81-AA80-6654E6B15B2B

P5875

Q28750566-CD40CE79-E120-4ABC-BA85-5132807546E4

P698

Q28750566-AC1EA055-09B0-47A3-A055-A4363BD113F0

P921

Q28750566-50B98172-5207-462C-AD77-E02D0FEE5B03

Q28750566-9B280BCC-04EB-47D6-AE84-A8ABC575A38D

P932

Q28750566-3D3BB05C-46F8-4118-BDE9-84DB491A9E57

P356

JOURNAL.PONE.0011437

P1433

P1476

Acquired antibody responses ag ...... receptor for chemokines (DARC)

@en

P2093

Akihide Takagi

http://www.w3.org/2001/XMLSchema#string

Amanda Maestre

http://www.w3.org/2001/XMLSchema#string

Carlos Muskus

http://www.w3.org/2001/XMLSchema#string

Francis B Ntumngia

http://www.w3.org/2001/XMLSchema#string

Ivan D Velez

http://www.w3.org/2001/XMLSchema#string

Kim Lee Sim

http://www.w3.org/2001/XMLSchema#string

Olga Agudelo

http://www.w3.org/2001/XMLSchema#string

Pu Liu

http://www.w3.org/2001/XMLSchema#string

Ruobing Wang

http://www.w3.org/2001/XMLSchema#string

Victoria Duque

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene

The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide

Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea

The Resistance Factor to Plasmodium vivax in Blacks

Detection of the signature of natural selection in humans: evidence from the Duffy blood group locus

Complex signatures of natural selection at the Duffy blood group locus

The global distribution of clinical episodes of Plasmodium falciparum malaria

Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people

Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region

Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility

P304

e11437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0011437

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Stephen L Hoffman

Giampietro Corradin

P577

2010-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45389622

http://www.w3.org/2001/XMLSchema#string

P698

20664684

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium vivax

P932

2896388

http://www.w3.org/2001/XMLSchema#string